20180306 
 
Time Opening Remark
09:00-09:05 Dr. Tzou-Yien Lin
Chair person, Board of Directors, NHRI, Taiwan
I. Taiwan Regulation Section
  Topic Speaker Moderator
09:05-09:30 Development of Enterovirus71 (EV71) Vaccines in Taiwan Dr. Min-Shi Lee
NHRI, Taiwan

Dr. Mei-Shang Ho
Academia SINICA, Taiwan
09:30-10:00 Clinical Perspective on EV 71 Vaccines Regulation in Taiwan Dr. Ya-Lei Wang
CDE, Taiwan
10:00-10:30 CMC Perspective on EV 71 Vaccines Regulation in Taiwan Dr. Yu-Ping Ho
CDE, Taiwan
10:45-11:15 Lot Release System for Vaccines in Taiwan Dr. Yi-Chen Yang
FDA, MOHW, Taiwan
11:15-11:40 Current Status and Future Plans for Clinical Trial of EV 71 Vaccines (Enimmune) Dr. Chin-Fen Yang
Enimmune, Taiwan
11:45-12:15 Current Status and Future Plans for Clinical Trial of EV 71 Vaccines (Medigen) Dr. Kathy Tai
Medigen Vaccines, Taiwan
II. Vietnam Regulation Section
13:30-14:00 Review on IND of Human Vaccines in Vietnam Dr. Nguyen Ngo Quang
ASTT, MOH,
Vietnam
Prof. Oliver Yoa-Pu Hu
Taipei Medical University, Taiwan
14:00-14:30 Regulati on on Surveillance of Adverse Event Following Immunization Dr. Nguyen Minh Hang
GDPM, MOH,
Vietnam
14:30-15:00 Implementation of Vaccine Trials in Vietnam, Experiences from the Pasteur Institute Ho Chi Minh City Dr. Nguyen Vu Thuong
Paster Institute-HCMC,
Vietnam
15:15-15:45 Experiences Sharingon Multi-national Clinical Trials of Pediatric Vaccines in Vietnam Dr. Nguyen Trong Toan
Paster Institute-HCMC,
Vietnam
Dr. Min-Shi Lee
NHRI, Taiwan
15:45-16:15 Cost of Illness of HFMD in Vietnam Dr. Le Nguyen Thanh Nhan
Children's Hospital 1,
HCMC, Vietnam
16:15-16:45 Experiences sharing on clinical trials of pediatric vaccines in Vietnam Dr. Do Tuan Dat
VABIOTECH Vaccine,
Vietnam

20180306